DK15281A - Fremgangsmaade til fremstilling af et biologisk aktivt stof til selektiv inhibering af proliferationen af leukaemiske og normale myeloide celler - Google Patents

Fremgangsmaade til fremstilling af et biologisk aktivt stof til selektiv inhibering af proliferationen af leukaemiske og normale myeloide celler

Info

Publication number
DK15281A
DK15281A DK15281A DK15281A DK15281A DK 15281 A DK15281 A DK 15281A DK 15281 A DK15281 A DK 15281A DK 15281 A DK15281 A DK 15281A DK 15281 A DK15281 A DK 15281A
Authority
DK
Denmark
Prior art keywords
radical
separates
value
referred
charge
Prior art date
Application number
DK15281A
Other languages
English (en)
Other versions
DK155712B (da
DK155712C (da
Inventor
A Balazs
M Sajgo
L Kisfaludy
T Klupp
M Barabas
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK15281A publication Critical patent/DK15281A/da
Publication of DK155712B publication Critical patent/DK155712B/da
Application granted granted Critical
Publication of DK155712C publication Critical patent/DK155712C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/838—Marrow; spleen
DK015281A 1980-01-15 1981-01-14 Fremgangsmaade til fremstilling af et oligopeptid, som selektivt inhiberer formeringen af normale og leukaemiske myeloide celler DK155712C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU6880 1980-01-15
HU8068A HU182087B (en) 1980-01-15 1980-01-15 Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia

Publications (3)

Publication Number Publication Date
DK15281A true DK15281A (da) 1981-07-16
DK155712B DK155712B (da) 1989-05-08
DK155712C DK155712C (da) 1989-09-25

Family

ID=10947737

Family Applications (1)

Application Number Title Priority Date Filing Date
DK015281A DK155712C (da) 1980-01-15 1981-01-14 Fremgangsmaade til fremstilling af et oligopeptid, som selektivt inhiberer formeringen af normale og leukaemiske myeloide celler

Country Status (9)

Country Link
US (1) US4384991A (da)
EP (1) EP0035102B1 (da)
JP (1) JPS56138118A (da)
AT (1) ATE5071T1 (da)
AU (1) AU542044B2 (da)
DE (1) DE3161195D1 (da)
DK (1) DK155712C (da)
HU (1) HU182087B (da)
SU (2) SU1367837A3 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085254A1 (en) * 1981-12-28 1983-08-10 Yoshio Sakagami Proteins and their extraction
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same
US5149544A (en) * 1989-11-13 1992-09-22 Research Corporation Technologies, Inc. Method of inhibiting progenitor cell proliferation
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
EP1640012A1 (de) * 2004-09-24 2006-03-29 Salama, Zoser B. nat.rer.Dr. Pharmazeutisches Mittel enthaltend Blutbestandteile 10 kDa und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems
US20060067942A1 (en) * 2004-09-24 2006-03-30 Salama Zoser B Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals
DE112005002912A5 (de) * 2004-09-24 2007-08-30 Salama, Zoser B. Pharmazeutisches Mittel umfassend Aminosäuren, Peptide, Proteine und/oder deren Bruchteile und Fragmente und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems bei Menschen und Tieren
DE102004047262A1 (de) * 2004-09-24 2006-04-06 Ipss International Pharmaceutical Strategies & Solutions Pharmazeutisches Mittel umfassend Blutprodukte und deren Verwendung als Injektions- oder Infusionsmittel zur Prophylaxe und Behandlung von Defekten des Immunsystems beim Menschen
PL1812399T3 (pl) 2004-11-04 2010-05-31 Mallinckrodt Inc Opiatowe produkty pośrednie oraz sposoby syntezy
US7622586B2 (en) * 2005-10-21 2009-11-24 Mallinckrodt Inc. Opiate intermediates and methods of synthesis
US7511060B2 (en) 2005-10-21 2009-03-31 Mallinckrodt Inc. Opiate intermediates and methods of synthesis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3973001A (en) * 1954-04-27 1976-08-03 Solco Basel Ag Tissue cell stimulating blood extracts
US3937816A (en) * 1970-07-21 1976-02-10 Solco Basel Ag Growth regulating compositions extracted from spleen
GB1579120A (en) * 1975-08-05 1980-11-12 Union International Co Ltd Extracts of the haemopoietic system

Also Published As

Publication number Publication date
SU1367837A3 (ru) 1988-01-15
AU542044B2 (en) 1985-02-07
EP0035102B1 (de) 1983-10-19
ATE5071T1 (de) 1983-11-15
EP0035102A1 (de) 1981-09-09
JPS56138118A (en) 1981-10-28
DK155712B (da) 1989-05-08
SU1228776A3 (ru) 1986-04-30
AU6620081A (en) 1982-04-22
HU182087B (en) 1983-12-28
DK155712C (da) 1989-09-25
US4384991A (en) 1983-05-24
DE3161195D1 (en) 1983-11-24

Similar Documents

Publication Publication Date Title
DK15281A (da) Fremgangsmaade til fremstilling af et biologisk aktivt stof til selektiv inhibering af proliferationen af leukaemiske og normale myeloide celler
Yip et al. Photoaffinity labeling of atrial natriuretic factor receptors of rat kidney cortex plasma membranes.
Dulak et al. A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication‐stimulating activity for embryo fibroblasts
Press et al. The N-and c-terminal amino acid sequences of the heavy chain from a pathological human immunoglobulin IgG
Wang et al. The 68,000-dalton neurofilament-associated polypeptide is a component of nonneuronal cells and of skeletal myofibrils
Harrington et al. A selective inhibitor of cell proliferation from normal serum.
Lowy et al. Solubilization of an α-bungarotoxin-binding component from rat brain
Kowarski et al. Intestinal membrane calcium-binding protein. Vitamin D-dependent membrane component of the intestinal calcium transport mechanism.
Chiari et al. Preincubation with cysteine prevents modification of sulfhydryl groups in proteins by unreacted acrylamide in a gel
Wang et al. Purification of band 7.2 b, a 31-kDa integral phosphoprotein absent in hereditary stomatocytosis.
Alais et al. Isolation, purification, and analysis of two κ-casein-like fractions from sheep casein
Mäkelä et al. Release of sialic acid and carbohydrates from human red cells by trypsin treatment
Regoeczi et al. Effects of clotting on the label in iodinated fibrinogen in different species
Stratton et al. The role of zeta potential in Rh agglutination
US4376071A (en) Mitogenic spinal cord growth factor
Jirgensons et al. A study of trypsin inhibitors
US4798800A (en) Process for isolating human globular domain NC1 of basal membrane collagen from human tissue
Hammond et al. Purification of insect myosin and alpha-actinin.
Nishioka et al. A binding activity of actin with human C1q
Pinder et al. Spectrin in primitive erythrocytes
Webster et al. A second activation peptide from bovine cationic trypsinogen
Sato et al. Cross-linking of intact erythrocyte membrane with a newly synthesized cleavable bifunctional reagent
Steinbuch et al. Technique de purification des immuno-globulines
HASHIMOTO et al. Presence of connectin-like protein in white blood cells and platelets
Kosower et al. A New Bromobimane Fluorescent Label for Anion Exchange Proteins

Legal Events

Date Code Title Description
PBP Patent lapsed